Table 1.
Total N = 171; 100% |
Treatment completed N = 100 (58.5%) |
Treatment not completed N = 71 (42.5%) |
p | |
---|---|---|---|---|
Demographic characteristics | ||||
% Women | 100% | 100% | 100% | NA |
Age mean (SD) | 49.4 (8.7) | 50.1 (9.0) | 48.3 (8.0) | 0.17 |
% Born in the Netherlandsa | 84.2% | 85.0% | 83.1% | 0.74 |
% Higher education | 53.2% | 59.0% | 45.1% | 0.07 |
% Living together | 78.9% | 79.0% | 78.9% | 0.98 |
% In a paid job | 78.9% | 80.0% | 77.5% | 0.69 |
% On sick leave | 47.4% | 38.8% | 60.0% | 0.02 |
Type of treatment | ||||
% Complete breast amputation | 60.8% | 64.0% | 56.3% | 0.31 |
Years between operation and admission to intervention, mean (SD) | 2.3 (2.1) | 2.4 (2.2) | 2.2 (2.0) | 0.62 |
% Radiotherapy | 65.5% | 66.0% | 64.8% | 0.87 |
% Chemotherapy | 77.8% | 77.0% | 78.9% | 0.77 |
% Hormonal therapy | 76.0% | 76.0% | 76.1% | 0.99 |
% With lymphe oedemia | 46.8% | 41.0% | 54.9% | 0.07 |
Sleep characteristics | ||||
Insomnia severity index, mean (SD) | 16.5 (3.6) | 16.1 (3.4) | 17.0 (3.9) | 0.11 |
Fatigue Severity Scale, mean (SD) | 39.3 (11.1) | 37.3 (11.1) | 42.2 (10.6) | < 0.01 |
% With sleep medication | 45.0% | 48.0% | 40.8% | 0.35 |
% Insomnia before breast cancer | 38.0% | 41.0% | 33.8% | 0.34 |
% Sleep medication in history | 25.7% | 29.0% | 21.1% | 0.25 |
% Other sleep treatment in history | 7.6% | 8.0% | 7.0% | 0.82 |
Psychological symptoms and functioning | ||||
HADS-anxiety | 7.6 (3.7) | 7.6 (3.7) | 7.6 (3.8) | 0.95 |
HADS-depression | 5.5 (3.7) | 5.2 (3.5) | 5.9 (4.0) | 0.20 |
WSAS functioning (total) | 16.2 (9.7) | 15.4 (9.6) | 17.3 (9.7) | 0.20 |
WSAS household | 3.9 (2.8) | 3.5 (2.6) | 4.5 (2.9) | 0.12 |
WSAS work | 4.5 (3.1) | 4.4 (3.1) | 4.6 (3.2) | 0.63 |
WSAS friendship | 3.8 (2.8) | 3.7 (2.7) | 4.0 (2.8) | 0.46 |
WSAS social functioning | 4.0 (2.7) | 3.9 (2.7) | 4.2 (2.8) | 0.48 |
% Medical referral | 33.5% | 33.0% | 34.5% | 0.86 |
Participant + both parents were born in the Netherlands.